Waiving a requirement of clause 6(a) of rule XIII with respect to consideration of certain resolutions reported from the Committee on Rules.

Summary

Waives a specified requirement of Rule XIII (Calendar and Committee Reports) to allow consideration of a bill (amending the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, and to enhance the postmarket authorities of the Food and Drug Administration (FDA) with respect to the safety of drugs) on the same day it is presented to the House.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

4 official files

• Reported in House (text)

  Reported in House · EN · 18 September 2007

  ViewDownloadOpen at official source

• Reported in House (PDF)

  Reported in House · EN · 18 September 2007

  ViewDownloadOpen at official source

• Reported to House without amendment

  summary · EN · 18 September 2007

  Open at official source

• Introduced in House

  summary · EN · 18 September 2007

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.